(1:09) Melissa Piliang, MD, of Cleveland Clinic, discusses comorbid chronic kidney disease in patients with psoriasis and psoriatic arthritis. (1:42) ...
Germany: A team of researchers from Germany developed a deep learning model using a convolutional neural network (CNN) to ...
Protagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated icotrokinra (JNJ-2113), an investigational targeted oral peptide that ...
STEQEYMA is available in both subcutaneous injection and intravenous infusion and is indicated for the treatment of plaque psoriasis (PsO) and psoriatic arthritis (PsA) in adult and pediatric ...
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...
It encompasses all indications approved for the STELARA ® reference product, including psoriasis (PsO), psoriatic arthritis (PsA), Crohn's disease (CD), ulcerative colitis (UC) in adults ...
Most common (≥ 2%) adverse reactions in psoriatic arthritis include upper respiratory tract infections, oral candidiasis, headache, diarrhea, and urinary tract infections. Most common (≥ 2% ...
Recent research captures more evidence on the psoriasis–type 2 diabetes link and attempts to pinpoint the possible genetic and pathophysiologic mechanisms underlying this connection. This study ...